Photodynamic therapy for companion animals with cancer

Veterinary Clinics of North America - Small Animal Practice

Volumn 32, Issue 3, 2002, Pages 693-702

  Lucroy, Michael D ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 ETHYLAMINO 9 DIETHYLAMINOBENZO[A]PHENOTHIAZINIUM CHLORIDE; AMINOLEVULINIC ACID; ANTIINFECTIVE AGENT; HEMATOPORPHYRIN; PHEOPHORBIDE A HEXYLETHER; PHOTOCHLOR; PHOTOFRIN; PHOTOSENSITIZING AGENT; PORPHYRIN; TEMOPORFIN; TETRASULFOPHTHALOCYANINE ALUMINUM; UNCLASSIFIED DRUG;

ARTICLE; BASAL CELL CARCINOMA; CANCER; CANCER THERAPY; CAT; CONTROLLED STUDY; DIODE LASER; DOG; DOSIMETRY; DRUG RESPONSE; DRUG SCREENING; FIBROSARCOMA; HEMANGIOPERICYTOMA; HISTORY OF MEDICINE; HUMAN; MASTOCYTOMA; MELANOMA; MOUSE; MOUTH CARCINOMA; NONHUMAN; PHOTOCHEMOTHERAPY; PHOTODYNAMIC THERAPY; PHOTODYNAMICS; PHOTON; PHOTOSENSITIVITY; SOLID TUMOR; SQUAMOUS CELL CARCINOMA; TREATMENT INDICATION; VETERINARY MEDICINE;

ANIMALIA; CANIS FAMILIARIS; FELIS CATUS;

EID: 0036269504     PISSN: 01955616     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-5616(02)00011-6     Document Type: Review

References (52)

1. Photodynamic therapy: A review
2. Photodynamic therapy
3. Photodynamic therapy
4. Photodynamic therapy in veterinary medicine: Current status and implications for application in human disease
5. Veterinary photodynamic therapy
6. A history of photodynamic therapy
7. Psoralen photobiology and photochemotherapy: 50 years of science and medicine
8. Sur l'action des alcaloides dans les regne vegetal et animal
9. Zer Behandlung der Hautcarcinomit mit fluorescierenden stoffen
10. Ueber die Wirkung fluorescierenden Stoffe auf Infusorien
11. Die sensibilisierende wirkung des hematoporphyrins
12. Cancer detection and therapy: Affinity of neoplastic embryonic and traumatized tissue for metalloporphyrins
13. Historical perspective
14. Hematoporphyrin derivative: A possible aid in the diagnosis and therapy of carcinoma of the bladder
15. Photoradiation therapy for the treatment of malignant tumors
16. Identification of singlet oxygen as the cytotoxic agent in photo-inactivation of a murine tumor
17. Photoradiation therapy of malignant tumors: Role of the laser
18. Interstitial photoirradiation therapy for primary solid tumors in pet cats and dogs
19. Hematoporphyrin derivative photochemotherapy of spontaneous tumors: Clinical results with optimized drug dose
20. Hematoporphyrin derivative and laser photoirradiation in the treatment of lung cancer
21. Laser photoradiation therapy of cancer following hematoporphyrin sensitization
22. Low density lipoprotein as a delivery vehicle in various applications of photodynamic therapy
23. The effect of tissue and cellular pH on the selective biodistribution of porphyrins-type photochemotherapeutic agents: A volumetric titration study
24. Lipid accumulation: The common feature to photosensitizer retaining normal and malignant tissues
25. The binding of tumor localizing porphyrins to a fibrin matrix and their effects following photoirradiation
26. Distribution of Photofrin between tumor cells and tumor associated macrophages
27. Photofrin uptake by murine macrophages
28. HPD: Structure and determinants of localization
29. Tumour photosensitizers: Approaches to enhance the selectivity and efficiency of photodynamic therapy
30. Evidence for low-density lipoprotein receptor-mediated uptake of benzoporhyrin derivative
31. Photodynamic therapy
32. Transmittance of nonionizing radiation in human tissues
33. In vivo and post mortem measurements of the attenuation spectra of light in mammalian tissues
34. PDT light dosimetry revisited
35. Light dosimetry in vivo
36. The determination of light fluence distributions in photodynamic therapy
37. Photodynamic and photothermia response of malignant tumors
38. Evaluation of photodynamic therapy-induced heating of hamster melanoma and its effect on local tumor irradiation
39. Effects of various photoirradiation regimens on antitumor efficacy of photodynamic therapy for R3230AC mammary carcinomas
40. Influence of fractionation and fluence rate in photodynamic therapy with Photofrin or mTHPC
41. How does photodynamic therapy work?
42. Photophysical and photobiological processes in the photodynamic therapy of tumours
43. The photobiology of photodynamic therapy: Cellular targets and mechanisms
44. The role of vascular photodamage in photodynamic therapy
45. Evidence for an important role of neutrophils in the efficacy of photodynamic therapy in vivo
46. Variation in the distribution of a phthalocyanine photosensitizer in naturally occurring tumors of animals
47. Photodynamic therapy for nasal and aural squamous cell carcinomas in cats
48. Photodynamic therapy of facial squamous cell carcinoma in cats using a new photosensitizer
49. Prognostic factors associated with radiotherapy of squamous cell carcinoma of the nasal plane in cats
50. Treatment of canine oral squamous cell carcinoma with photodynamic therapy
51. Photodynamic inactivation of retrovirus by benzoporphyrin derivative: A feline leukemia virus model
52. Killing of cutaneous microbial species by photodynamic therapy